Method for treating vascular hyperpermeable disease
CA 2520957 C · Owner: Inoue, Takayuki · Inventors: Inoue, Takayuki; Ohkubo, Mitsuru; Nagashima, Akira
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method for treating a vascular hyperpermeable disease (except macular edema), which method comprises administering to a patient in need thereof a vascular adhesion protein-1 (VAP-1) inhibitor in an amount sufficient to treat said patient for said disease. The agents are 2acylamino thiazole compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 31, 2004 and granted August 6, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 31, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 31, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.